Abstract

BackgroundUse of a risk of bias (ROB) tool has been encouraged and advocated to reviewers writing systematic reviews (SRs) and meta-analyses (MAs). Selective outcome reporting and other sources of bias are included in the Cochrane ROB tool. It is important to know how this specific tool for assessing ROB has been applied since its release. Our objectives were to evaluate whether and to what extent the new Cochrane ROB tool has been used in Chinese journal papers of acupuncture.MethodsWe searched CBM, TCM database, CJFD, CSJD, and the Wanfang Database from inception to March 2011. Two reviewers independently selected SRs that primarily focused on acupuncture and moxibustion, from which the data was extracted and analyzed.ResultsA total of 836 SRs were identified from the search, of which, 105 were included and four are awaiting assessment. Thirty-six of the 105 SRs were published before release of the Cochrane ROB tool (up to 2009). Most used the Cochrane Handbook 4.2 or Jadad's scale for risk or quality assessment. From 2009 to March 2011 69 SRs were identified. While “risk of bias” was reported for approximately two-thirds of SRs, only two SRs mentioned use of a “risk of bias tool” in their assessment. Only 5.8% (4/69) of reviews reported information on all six domains which are involved in the ROB tool. A risk of bias graph/summary figure was provided in 2.9% (2/69) of reviews. Most SRs gave information about sequence generation, allocation concealment, blindness, and incomplete outcome data, however, few reviews (5.8%; 4/69) described selective reporting or other potential sources of bias.ConclusionsThe Cochrane “risk of bias” tool has not been used in all SRs/MAs of acupuncture published in Chinese Journals after 2008. When the ROB tool was used, reporting of relevant information was often incomplete.

Highlights

  • Assessment of internal validity, risk of bias, or methodological quality of studies included in systematic reviews (SRs) and metaanalyses (MAs) is a very important step in identifying limitations of individual studies

  • Since the 1980s, numerous tools involving scales and checklists have been developed for assessing the methodological quality of clinical trials [1], including the Cochrane Collaboration’s ‘‘risk of bias’’ (ROB) tool which was published in 2008 [2]

  • We evaluate whether and to what extent the Cochrane ROB tool has been used in SRs of acupuncture published in Chinese journals

Read more

Summary

Introduction

Assessment of internal validity, risk of bias, or methodological quality of studies included in systematic reviews (SRs) and metaanalyses (MAs) is a very important step in identifying limitations of individual studies. Since the 1980s, numerous tools involving scales and checklists have been developed for assessing the methodological quality of clinical trials [1], including the Cochrane Collaboration’s ‘‘risk of bias’’ (ROB) tool which was published in 2008 [2]. It addresses six specific domains: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other sources of bias. In these six domains, the judgments of ‘Yes’, ‘No’, or ‘Unclear’ indicates ‘low risk of bias’, ‘high risk of bias’, and ‘uncertain risk of bias’, respectively’’ [2]. Our objectives were to evaluate whether and to what extent the new Cochrane ROB tool has been used in Chinese journal papers of acupuncture

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call